Medy-Tox Inc. (KOSDAQ:A086900) announces a share repurchases program. Under the program, the company will repurchase up to 43,821 shares. The purpose of the buyback is to stabilize stock price and increase shareholder value.

The plan will be valid up to May 18, 2022. As of February 18, 2022, the company had 458,833 shares in treasury within scope available for dividend and had 28,538 common stock and 7 other stock in treasury through other repurchase.